Cargando…
Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin
Galectins are small soluble lectins that bind β-galactosides via their carbohydrate recognition domain (CRD). Their ability to dimerize is critical for the crosslinking of glycoprotein receptors and subsequent cellular signaling. This is particularly important in their immunomodulatory role via the...
Autores principales: | Vladoiu, Maria Claudia, Labrie, Marilyne, Létourneau, Myriam, Egesborg, Philippe, Gagné, Donald, Billard, Étienne, Grosset, Andrée-Anne, Doucet, Nicolas, Chatenet, David, St-Pierre, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747383/ https://www.ncbi.nlm.nih.gov/pubmed/26543238 |
Ejemplares similares
-
Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells
por: Grosset, Andrée-Anne, et al.
Publicado: (2014) -
Expression and functions of galectin-7 in ovarian cancer
por: Labrie, Marilyne, et al.
Publicado: (2014) -
Galectin signatuares contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets
por: Grosset, Andrée-Anne, et al.
Publicado: (2016) -
A Mutation in the Carbohydrate Recognition Domain Drives a Phenotypic Switch in the Role of Galectin-7 in Prostate Cancer
por: Labrie, Marilyne, et al.
Publicado: (2015) -
The CCAAT/Enhancer-Binding Protein Beta-2 Isoform (CEBPβ-2) Upregulates Galectin-7 Expression in Human Breast Cancer Cells
por: Campion, Carole G., et al.
Publicado: (2014)